MUSTANG BIO, INC.
MBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001680048
Insider trades, last 90 days
None
- No open-market purchases or sales were filed in the last 90 days.
13F holders, Q2 2026
23
- +1 vs. Q1 2026
- Total value $378.3K
Superinvestors holding MBIO
0
- None of the superinvestors held MBIO at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by MBIO insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Dec 30, 2025 | Dec 30, 2025 | Herskowitz NeilDirector | SSaleCOMMON STOCK, PAR VALUE $0.0001 | −247 | $0.96 | −$237.12 | 145 | −63.0% | SEC |
| Dec 30, 2025 | Dec 30, 2025 | Chill Adam J.Director | SSaleCOMMON STOCK, PAR VALUE $0.0001 | −4 | $0.95 | −$3.8 | 375 | −1.1% | SEC |
| Dec 30, 2025 | Dec 30, 2025 | Jin DavidDirector | PPurchaseCOMMON STOCK, PAR VALUE $0.0001 | +247 | $0.96 | +$237.12 | 286 | +633.3% | SEC |
| Apr 3, 2023 | Mar 18 – Sep 13, 2022 | Litchman Manuel MDDirector | PPurchaseCOMMON STOCK, PAR VALUE $0.0001 | +10K | $0.63 | +$6.3K | 1.1M | +0.9% | SEC |
| Apr 3, 2023 | Mar 18 – Sep 13, 2022 | ROSENWALD LINDSAY A MDDirector | PPurchaseCOMMON STOCK, PAR VALUE $0.0001 | +9.09K | $0.619 | +$5.63K | 299.18K | +3.1% | SEC |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in MBIO at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Kestra Advisory Services, LLC | 196,991 | $138.29K | 0.00% | +20,949+11.9% | Added |
| BlackRock, Inc. | 84,745 | $59.49K | 0.00% | 00.0% | Unchanged |
| CITADEL ADVISORS LLC | 59,459 | $41.74K | 0.00% | +6,259+11.8% | Added |
| GEODE CAPITAL MANAGEMENT, LLC | 42,240 | $29.65K | 0.00% | −50,550−54.5% | Reduced |
| CFO4Life Group, LLC | 33,510 | $23.52K | 0.00% | +13,049+63.8% | Added |